299. 嚢胞性線維症
[臨床試験数:1,592,薬物数:1,539(DrugBank:255),標的遺伝子数:81,標的パスウェイ数:162

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02564354
(ClinicalTrials.gov)
September 201529/9/2015Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ?F508 CFTR MutationOpen-Label, Exploratory Study to Evaluate the Effects of QR-010 on Nasal Potential Difference in Subjects With CF With the ?F508 CFTR MutationCystic FibrosisDrug: QR-010ProQR TherapeuticsEuropean CommissionCompleted18 YearsN/AAll18Phase 1United States;Belgium;France
2NCT02532764
(ClinicalTrials.gov)
June 201513/8/2015Dose Escalation Study of QR-010 in Homozygous ?F508 Cystic Fibrosis PatientsPhase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ?F508 Cystic FibrosisCystic FibrosisDrug: QR-010;Drug: PlaceboProQR TherapeuticsEuropean CommissionCompleted18 Years60 YearsAll70Phase 1;Phase 2United States;Belgium;Canada;Czechia;Denmark;France;Germany;Italy;Spain;United Kingdom;Czech Republic;Netherlands